-
1 Comment
Lyka Labs Limited is currently in a long term uptrend where the price is trading 74.6% above its 200 day moving average.
From a valuation standpoint, the stock is 74.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
Lyka Labs Limited's total revenue rose by 46.1% to $268M since the same quarter in the previous year.
Its net income has increased by 94.5% to $-23M since the same quarter in the previous year.
Finally, its free cash flow fell by 28.8% to $35M since the same quarter in the previous year.
Based on the above factors, Lyka Labs Limited gets an overall score of 4/5.
| Exchange | NSE |
|---|---|
| CurrencyCode | INR |
| Sector | Healthcare |
| Industry | Biotechnology |
| ISIN | INE933A01014 |
| Beta | 0.64 |
|---|---|
| Market Cap | 4B |
| PE Ratio | 97.58 |
| Target Price | None |
| Dividend Yield | None |
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LYKALABS.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
